Prednisone Plus Azathioprine Treatment in Patients With Rheumatoid Arthritis Complicated by Vasculitis

Archives of Internal Medicine

Volumn 151, Issue 11, 1991, Pages 2249-2254

  Heurkens, Antonius H M ^a   Westedt, Marie Louise ^a   Breedveld, Ferdinand C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; PREDNISONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VASCULITIS;

AGED; ARTHRITIS, RHEUMATOID; AZATHIOPRINE; COMPARATIVE STUDY; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; MALE; PREDNISONE; VASCULITIS;

EID: 0025876201     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1991.00400110099020     Document Type: Article

References (45)

1. Scott DGI, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine. 1981;60:288-297.
2. Ansell BM, Loewi G. Rheumatoid arthritis: general features. Clin Rheum Dis. 1977;3:385-401.
3. Lakhanpal S, Conn DL, Lie JT. Clinical and prognostic significance of vasculitis as an early manifestation of connective tissue disease syndromes. Ann Intern Med. 1984;101:743-748.
4. Geirsson AJ, Sturfelt G, Truedsson L. Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. Ann Rheum Dis. 1987;46:727-733.
5. Sokoloff L, Wilens SL, Bunim JJ. Arteritis of striated muscle in rheumatoid arthritis. Am J Pathol. 1951;27:157-173.
6. Sokoloff L, Bunim JJ. Vascular lesions in rheumatoid arthritis. J Chronic Dis. 1957;5:668-687.
7. Scott DGI, Bacon PA. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med. 1984;76:377-384.
8. Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958;9:175-176.
9. Kaufmann RH, van Es LA, Daha MR. Aggregated human immunoglobulin G stabilized by albumin: a standard for immune complex detection. J Immunol Methods. 1979;31:11-22.
10. Otten MR, Daha MR, de Rooij HH, Breedveld FC. Quantitative detection of class-specific rheumatoid factors using mouse monoclonal antibodies and the biotin/streptavidin enhancement system. Br J Rheumatol. 1989;28:310-316.
11. Bywaters EGL, Scott JT. The natural history of vascular lesions in rheumatoid arthritis. J Chronic Dis. 1963;16:905-914.
12. Ferguson RH, Slocomb CH. Peripheral neuropathy in rheumatoid arthritis. Bull Rheum Dis. 1961;9:251-254.
13. Bacon PA. Vasculitis: clinical aspects and therapy. Acta Med Scand. 1987;715:157-163.
14. Abel T, Andrews BS, Cunningham PH, et al. Rheumatoid vasculitis: effect of cyclophosphamide on the clinical course and levels of circulating immune complexes. Ann Intern Med. 1980;93:407-413.
15. Schmid FR, Cooper NS, Ziff M, McEwen C. Arteritis in rheumatoid arthritis. Am J Med. 1961;30:56-83.
16. Wilkinson M, Torrance WN. Clinical background of rheumatoid vascular disease. Ann Rheum Dis. 1967;26:475-480.
17. Bacon PA. Rheumatoid vasculitis. In: McCarty DJ, ed. Arthritis and Allied Conditions. 11th ed. London, England: Lea & Febiger; 1989:1971-1974.
18. Van Albada-Kuipers GA, Bruijn JA, Westedt ML, Breedveld FC, Eulderink F. Coronary arteritis complicating rheumatoid arthritis. Ann Rheum Dis. 1986;45:963-965.
19. Scott DGI. Treatment of rheumatoid vasculitis (RV). In: Program and abstracts of the proceedings of the International League Against Rheumatism 1989 Congress; September 17-23, 1989; Rio de Janeiro, Brazil. Pages 112-113.
20. Nicholls A, Snaith ML, Maini RN, Scott JT. Controlled trial of azathioprine in rheumatoid vasculitis. Ann Rheum Dis. 1973;32:589-591.
21. Currey HLF, Harris J, Mason RM, et al. Comparison of azathioprine, cyclophosphamide and gold in treatment of rheumatoid arthritis. BMJ. 1974;3:763-766.
22. Levy J, Paulus HE, Bangert R. Comparison of azathioprine (AZ) and cyclophosphamide (CPA) in the treatment of rheumatoid arthritis (RA). Arthritis Rheum. 1975;18:412-413. Abstract.
23. Ebert RH, Barclay WR. Changes in connective tissue reaction induced by cortisone. Ann Intern Med. 1952;37:506-518.
24. Snyder DS, Unanue ER. Corticosteroids inhibit murine macrophage la expression and interleukin 1 production. J Immunol. 1982;129:1803-1805.
25. Hurd ER. Immunosuppressive and antiinflammatory properties of cyclophosphamide, azathioprine and methotrexate. Arthritis Rheum. 1973;16:84-88.
26. Steinberg AD. Efficacy of immunosuppressive drugs in rheumatoid diseases. Arthritis Rheum. 1973;16:92-96.
27. Urowitz MB, Gordon DA, Smythe HA, Pruzanski W, Ogryzlo MA. Azathrioprine in rheumatoid arthritis: a double-blind, cross-over study. Arthritis Rheum. 1973;16:411-418.
28. Levin RH, Landy M, Frei E. The effect of 6-mercaptopurine on immune response in man. N Engl J Med. 1964;271:16-22.
29. Murray JE, Barnes BA, Atkinson J. Fifth report of the human kidney transplant registry. Transplantation. 1967;5:752-774.
30. Frohnert PP, Sheps SG. Long-term follow-up study of periateritis nodosa. Am J Med. 1967;43:8-14.
31. Choy DSJ, Gould WJ, Gearhart RP, Sauer J. Remission in Wegener’s granulomatosis treated with steroids and azathioprine. N Y State J Med. 1969;69:1205-1209.
32. Bouroncle BA, Smith EJ, Cuppage FE. Treatment of Wegener’s granulomatosis with Imuran. Am J Med. 1967;42:314-318.
33. Wolff SM, Fauci AS, Horn RG, Dale DC. Wegener’s granulomatosis. Ann Intern Med. 1974;81:513-525.
34. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983;98:76-85.
35. Leib ES, Restivo C, Paulus HE. Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med. 1979;67:941-947.
36. Yazici H, Pazarli H, Barnes CG, et al. A controlled trial of azathioprine in Behçet’s syndrome. N Engl J Med. 1990;322:281-285.
37. De Silva M, Hazleman BL. Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis. 1986;45:136-138.
38. Norton WL, Suki W, Strunk S. Combined corticosteroids and azathioprine therapy in two patients with Wegener’s granulomatosis. Arch Intern Med. 1968;121:554-560.
39. Van der Woude FJ, Arisz L, Meijer S, Donker AJM, Hoedemaeker PhJ, van Overbeek JJM. Wegener’s granulomatosis: a clinicopathological study in twelve patients. Neth J Med. 1978;21:205-220.
40. Bunch TW, O’Duffy JD. Disease-modifying drugs for progressive rheumatoid arthritis. Mayo Clin Proc. 1980;55:161-179.
41. Bradley JD, Brandt KD, Katz BP. Infectious complications of cyclophosphamide treatment for vasculitis. Arthritis Rheum. 1989;32:45-53.
42. Decker JL. Toxicity of immunosuppressive drugs in man. Arthritis Rheum. 1973;16:89-91.
43. Whisnant JK, Pelkey J. Rheumatoid arthritis: treatment with azathioprine (Imuran[R]): clinical side-effects and laboratory abnormalities. Ann Rheum Dis. 1982;41(suppl 1):44-47.
44. Conn DL, McDuffie FC, Dyck PJ. Immunopathologic study of sural nerves in rheumatoid arthritis. Arthritis Rheum. 1972;15:135-143.
45. Westedt ML, Daha MR, de Vries E, Valentijn RM, Cats A. IgA containing immune complexes in rheumatoid vasculitis and in active rheumatoid disease. J Rheumatol. 1985;12:449-455.